For Patients

Antiretroviral drugs used in the treatment of HIV infection

Drugs Used in the Treatment of HIV Infection

Click on drug brand name for additional information.

Multi-class Combination Products

 Brand Generic Name Approval Date Time to Approval
 Atripla  efavirenz, emtricitabine and tenofovir disoproxil fumarate  12-July-06  2.5 months
 Complera  emtricitabine, rilpivirine, and tenofovir disoproxil fumarate  10-August-11  6 months
 Stribild  elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate  27-August-12  6 months

Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs);

Brand Name Generic Name Approval Date Time to Approval
 Combivir  lamivudine and zidovudine  27-Sep-97  3.9 months
 Emtriva  emtricitabine, FTC  02-Jul-03  10 months
 Epivir  lamivudine, 3TC  17-Nov-95  4.4 months
 Epzicom  abacavir and lamivudine  02-Aug-04  10 months
 Hivid  zalcitabine, dideoxycytidine, ddC (no longer marketed)  19-Jun-92  7.6 months
 Retrovir  zidovudine, azidothymidine, AZT, ZDV  19-Mar-87  3.5 months
 Trizivir  abacavir, zidovudine, and lamivudine  14-Nov-00  10.9 months
 Truvada  tenofovir disoproxil fumarate and emtricitabine  02-Aug-04  5 months
 Videx EC  enteric coated didanosine, ddI EC  31-Oct-00  9 months
 Videx  didanosine, dideoxyinosine, ddI  9-Oct-91  6 months
 Viread  tenofovir disoproxil fumarate, TDF  26-Oct-01  5.9 months
 Zerit  stavudine, d4T  24-Jun-94  5.9 months
 Ziagen  abacavir sulfate, ABC  17-Dec-98  5.8 months

 

 Brand Name Generic Name Approval Date Time to Approval
 Edurant  rilpivirine  20-May-11  10 months
 Intelence  etravirine  18-Jan-08  6 months
 Rescriptor  delavirdine, DLV  4-Apr-97  8.7 months
 Sustiva  efavirenz, EFV  17-Sep-98  3.2 months
 Viramune(Immediate Release)  nevirapine, NVP  21-Jun-96  3.9 months
 Viramune XR (Extended Release)  nevirapine, NVP  25-Mar-11  9.9 months

Protease Inhibitors (PIs) 

 Brand Name Generic Name Approval Date Time to Approval
 Agenerase  amprenavir, APV (no longer marketed) 15-Apr-99  6 months
 Aptivus  tipranavir, TPV  22-Jun-05  6 months
 Crixivan  indinavir, IDV,  13-Mar-96  1.4 months
 Fortovase  saquinavir (no longer marketed)  7-Nov-97  5.9 months
 Invirase  saquinavir mesylate, SQV  6-Dec-95  3.2 months
 Kaletra lopinavir and ritonavir, LPV/RTV  15-Sep-00  3.5 months
 Lexiva  Fosamprenavir Calcium, FOS-APV  20-Oct-03  10 months
 Norvir  ritonavir, RTV  1-Mar-96  2.3 months
 Prezista  darunavir  23-Jun-06  6 months
 Reyataz  atazanavir sulfate, ATV  20-Jun-03  6 months
 Viracept nelfinavir mesylate, NFV  14-Mar-97  2.6 months

Fusion Inhibitors

 Brand Name Generic Name  Approval Date  Time to Approval
 Fuzeon  enfuvirtide, T-20  13-Mar-03  6 months

 Entry Inhibitors - CCR5 co-receptor antagonist

 Brand Name Generic Name Approval Date Time to Approval
 Selzentry  maraviroc  06-August-07  8 months

 HIV integrase strand transfer inhibitors

 
 Brand Name Generic Name Approval Date Time to Approval
 Isentress  raltegravir  12--Oct-07  6 months
 Tivicay disclaimer icon  dolutegravir  13-August-13  6 months

 

Generic drugs used in the Treatment of HIV Infection

Approved and Tentatively Approved Antiretrovirals in Association with the President's Emergency Plan (PEPFAR)

Page Last Updated: 10/08/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.